Response of peritoneal solid tumours after intraperitoneal chemohyperthermia treatment with cisplatin or carboplatin.
about
Peritoneal Carcinomatosis from Colon Cancer: A Systematic Review of the Data for Cytoreduction and Intraperitoneal ChemotherapyA phase I study with an expanded cohort to assess the feasibility of intraperitoneal carboplatin and intravenous paclitaxel in untreated ovarian, fallopian tube, and primary peritoneal carcinoma: A Gynecologic Oncology Group study.The feasibility of administering varying high-dose consolidation hyperthermic intraperitoneal chemotherapy with carboplatin in the treatment of ovarian carcinoma.Consolidation hyperthermic intraperitoneal chemotherapy and maintenance chemotherapy following laparoscopic cytoreductive surgery in the treatment of ovarian carcinoma.Sodium arsenite and hyperthermia modulate cisplatin-DNA damage responses and enhance platinum accumulation in murine metastatic ovarian cancer xenograft after hyperthermic intraperitoneal chemotherapy (HIPEC)Hyperthermic intraperitoneal chemoperfusion in the treatment of locally advanced intra-abdominal cancer.Synergistic effects of cisplatin chemotherapy and gold nanorod-mediated hyperthermia on ovarian cancer cells and tumors.Peritoneal carcinosis of ovarian origin.Comparison of hyperthermia and adrenaline to enhance the intratumoral accumulation of cisplatin in a murine model of peritoneal carcinomatosis.Intraperitoneal therapy for peritoneal cancer.Fiberoptic microneedle device facilitates volumetric infusate dispersion during convection-enhanced delivery in the brain.Cytoreductive surgery and intraoperative hyperthermic chemoperfusion for advanced ovarian carcinoma.Recent advances in the treatment of peritoneal dissemination of gastrointestinal cancers by nucleoside antimetabolites.Laser photochemotherapy: a less invasive approach for treatment of cancer.Direct measurement of doxorubicin concentration in the intact, living single cancer cell during hyperthermia.The emerging role of molecular imaging and targeted therapeutics in peritoneal carcinomatosis.Enhancing the efficacy of cisplatin in ovarian cancer treatment - could arsenic have a role.Current status and future strategies of cytoreductive surgery plus intraperitoneal hyperthermic chemotherapy for peritoneal carcinomatosisHyperthermic intraperitoneal chemotherapy with and without cytoreductive surgery for epithelial ovarian cancer.Radioimmunotherapy for peritoneal cancers.Cytoreductive surgery for advanced ovarian cancer.Statement by the Kommission OVAR of the AGO Study Group on the Use of HIPEC (Hyperthermic Intraperitoneal Chemotherapy) to Treat Primary and Recurrent Ovarian CancerConsolidation hyperthermic intraperitoneal chemotherapy for the treatment of advanced stage ovarian carcinoma: a 3 year experience.Current status and future prospects of hyperthermic intraoperative intraperitoneal chemotherapy (HIPEC) clinical trials in ovarian cancer.Effects of hyperthermia in neutralising mechanisms of drug resistance in non-muscle-invasive bladder cancer.Hyperthermia generated with ferucarbotran (Resovist®) in an alternating magnetic field enhances cisplatin-induced apoptosis of cultured human oral cancer cells.Hyperthermic intraperitoneal perfusion chemotherapy and response evaluation in patients with gastric cancer and malignant ascites.Enhanced efficacy of combined 213Bi-DTPA-F3 and paclitaxel therapy of peritoneal carcinomatosis is mediated by enhanced induction of apoptosis and G2/M phase arrest.Drug resistance, illustration of the complexity of translational research. Steiner Award lecture 1995.Strategies to decrease the incidence of intra-abdominal recurrence in resectable gastric cancer.Treatment of peritoneal dissemination from gastric cancer by peritonectomy and chemohyperthermic peritoneal perfusion.Pilot study of intraperitoneal administration of paclitaxel and oral S-1 for patients with peritoneal metastasis due to advanced gastric cancer.Intra-abdominal temperature distribution during consolidation hyperthermic intraperitoneal chemotherapy with carboplatin in the treatment of advanced stage ovarian carcinoma.Safety and efficacy of hyperthermic intraperitoneal chemoperfusion with high-dose oxaliplatin in patients with peritoneal carcinomatosis.[Intraoperative (hyperthermic) intraperitoneal chemotherapy--considerations and aspects of safe intra- and postoperative treatment with cytostatic drugs]Peritoneal cancer index as a predictor of survival in advanced stage serous epithelial ovarian cancer: a prospective study.
P2860
Q31031044-4811A9F5-56C9-49E6-96CB-2F2F9DB65617Q33393909-CA00D68F-9BFF-4754-8F8A-4188FB986874Q33419382-75D4403F-5931-4DE7-9858-D76226F64B2CQ33419612-353C935F-4027-46B5-808C-ABB8B85C26FBQ33940195-DD149EFA-9045-4B52-95AA-1E2D60EC587AQ33994410-38D1F8CE-1829-4DA1-B8AB-28AE68D3F26DQ34006264-FD6AF933-8EEB-4CE2-801D-9173C990D62CQ34391112-F27EF6F4-02B9-4089-B198-74F5E63B89A2Q34510371-6BB6488E-B70A-4AC5-82BB-0A4396B9DBC1Q34789701-71C097CA-5AAD-48A1-967C-B836A2FA73A8Q34824767-6C8048E4-DE0E-4664-A7EA-09A976195C1EQ36103638-66C193B5-C3B4-4E27-B832-1ABD31DB491DQ36628679-6DF7F582-1EC0-48CF-915E-9DA391108907Q36670210-64EF2888-B853-4B11-9F08-25EAF79912FEQ36843911-C36CC0B8-0461-4EF2-A700-9625C54EC271Q36903804-4AEA4FB0-B6FD-4EEB-9353-E0044C812DC8Q37085878-AC1CF12D-47A1-40CB-B744-3261BBA39955Q37094755-618128CE-5E34-4B72-AD39-B3CFFDDC14BDQ37252047-2508A52E-33F4-4095-AC49-B1C2AF4016FEQ38096059-3CBCCC8E-9C1C-4D02-B641-D8CDD60A18D7Q38193876-7E16F11D-6675-4F0A-9550-5F36B5533860Q38464032-2D3B4973-0A62-426F-8FFA-0735535DD453Q38698167-0965F86E-8A89-4080-9AAA-68ABBA80BB77Q38769834-C002FB19-002F-4BBF-AFCC-427EF84BF635Q38813394-E877162C-A373-4755-A58D-E751A4C8D932Q39016433-448489C8-9F28-44AA-8DA4-62F42C86A1C3Q39151711-41848B13-9EE9-4B76-B5B3-25F7E667A2E4Q39300912-3876C709-A2F2-40D3-8930-443DD08F733AQ40968568-9744DF27-0711-4CCA-A42A-CC9B9CD9FE7BQ41025830-B9F3463D-5F71-4931-9B0F-4A5F105EAD9CQ45288550-531D8442-BDD4-4371-9A96-492AE00B9190Q46192224-335308D5-5AFC-4BF7-AB45-6500E2EA2941Q46840175-BFFDD156-B736-449B-B384-A078822B2754Q46932131-5577A211-B917-4A69-9BE2-28C4F605131DQ53976656-06D257FB-83D3-4F7C-8029-903DC36C9982Q55383792-975B8F73-D8DB-42FF-ADF0-E5597EF18593
P2860
Response of peritoneal solid tumours after intraperitoneal chemohyperthermia treatment with cisplatin or carboplatin.
description
1994 nî lūn-bûn
@nan
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
1994年论文
@zh
1994年论文
@zh-cn
name
Response of peritoneal solid t ...... with cisplatin or carboplatin.
@en
Response of peritoneal solid t ...... with cisplatin or carboplatin.
@nl
type
label
Response of peritoneal solid t ...... with cisplatin or carboplatin.
@en
Response of peritoneal solid t ...... with cisplatin or carboplatin.
@nl
prefLabel
Response of peritoneal solid t ...... with cisplatin or carboplatin.
@en
Response of peritoneal solid t ...... with cisplatin or carboplatin.
@nl
P2093
P2860
P356
P1476
Response of peritoneal solid t ...... with cisplatin or carboplatin.
@en
P2093
P2860
P2888
P304
P356
10.1038/BJC.1994.45
P407
P577
1994-02-01T00:00:00Z